Payment overview · 2025
General Payments
$95.56
5 reported records · 3 companies
Healthcare provider profile · identity verified
Manoj Patel, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TOMS RIVER, NJ · NPI 1184898918
Verified facts
What the public records show
CMS Open Payments records show Manoj Patel, MD received $95.56 in general payments during 2025 across 5 reported records.
Exact Sciences Corporation accounted for 66.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $63.69 | 66.7% | 3 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $16.56 | 17.3% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $15.31 | 16.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $95.56 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $45.41 | 2 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $18.28 | 1 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $16.56 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $15.31 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1039 | 204 |
| Amlodipine Besylate | Amlodipine Besylate | 635 | 127 |
| Levothyroxine Sodium | Levothyroxine Sodium | 622 | 109 |
| Gabapentin | Gabapentin | 607 | 109 |
| Furosemide | Furosemide | 502 | 108 |
| Metoprolol Succinate | Metoprolol Succinate | 471 | 90 |
| Eliquis | Apixaban | 454 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 408 | 91 |
| Tamsulosin Hcl | Tamsulosin Hcl | 389 | 72 |
| Omeprazole | Omeprazole | 370 | 93 |
| Losartan Potassium | Losartan Potassium | 350 | 64 |
| Lisinopril | Lisinopril | 336 | 60 |
| Metformin Hcl | Metformin Hcl | 302 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 273 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 259 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 255 | 43 |
| Simvastatin | Simvastatin | 231 | 45 |
| Potassium Chloride | Potassium Chloride | 222 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 218 | 45 |
| Sertraline Hcl | Sertraline Hcl | 218 | 41 |
| Famotidine | Famotidine | 217 | 39 |
| Carvedilol | Carvedilol | 212 | 51 |
| Trazodone Hcl | Trazodone Hcl | 206 | 35 |
| Finasteride | Finasteride | 195 | 36 |
| Donepezil Hcl | Donepezil Hcl | 186 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 185 | 18 |
| Divalproex Sodium | Divalproex Sodium | 179 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 171 | 65 |
| Mirtazapine | Mirtazapine | 166 | 34 |
| Olanzapine | Olanzapine | 147 | 17 |
| Levetiracetam | Levetiracetam | 128 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 46 |
| Glipizide Er | Glipizide | 115 | 26 |
| Allopurinol | Allopurinol | 114 | 20 |
| Prednisone | Prednisone | 114 | 55 |
| Farxiga | Dapagliflozin Propanediol | 113 | 15 |
| Meloxicam | Meloxicam | 112 | 32 |
| Xarelto | Rivaroxaban | 111 | 16 |
| Montelukast Sodium | Montelukast Sodium | 105 | 19 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 104 | 36 |
| Januvia | Sitagliptin Phosphate | 100 | 12 |
| Memantine Hcl | Memantine Hcl | 100 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 98 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 95 | 17 |
| Warfarin Sodium | Warfarin Sodium | 93 | suppressed |
| Spironolactone | Spironolactone | 92 | 15 |
| Latanoprost | Latanoprost | 91 | 17 |
| Enulose | Lactulose | 89 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 89 | 27 |
| Buspirone Hcl | Buspirone Hcl | 83 | 17 |
| Sucralfate | Sucralfate | 77 | 22 |
| Alprazolam | Alprazolam | 75 | 31 |
| Metformin Hcl Er | Metformin Hcl | 75 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 73 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 72 | 54 |
| Breo Ellipta | Fluticasone/Vilanterol | 72 | 20 |
| Nifedipine Er | Nifedipine | 72 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 69 | 16 |
| Ozempic | Semaglutide | 68 | 11 |
| Midodrine Hcl | Midodrine Hcl | 67 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 66 | 20 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 66 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 65 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 24 |
| Risperidone | Risperidone | 63 | 12 |
| Torsemide | Torsemide | 61 | 14 |
| Enalapril Maleate | Enalapril Maleate | 59 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 59 | 16 |
| Valsartan | Valsartan | 58 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 56 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 13 |
| Oxcarbazepine | Oxcarbazepine | 56 | suppressed |
| Atenolol | Atenolol | 55 | 14 |
| Ezetimibe | Ezetimibe | 55 | 16 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 55 | suppressed |
| Brilinta | Ticagrelor | 54 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 11 |
| Digoxin | Digoxin | 54 | suppressed |
| Nystatin | Nystatin | 52 | 31 |
| Glipizide | Glipizide | 51 | 12 |
| Repaglinide | Repaglinide | 51 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 50 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 48 | suppressed |
| Entresto | Sacubitril/Valsartan | 48 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 47 | 23 |
| Meclizine Hcl | Meclizine Hcl | 46 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 46 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 45 | 16 |
| Cephalexin | Cephalexin | 44 | 30 |
| Insulin Lispro | Insulin Lispro | 44 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 44 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | suppressed |
| Lamotrigine | Lamotrigine | 43 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 29 |
| Lorazepam | Lorazepam | 38 | 16 |
| Bumetanide | Bumetanide | 37 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 37 | 14 |
| Azithromycin | Azithromycin | 36 | 32 |
| Clonazepam | Clonazepam | 36 | suppressed |
| Aripiprazole | Aripiprazole | 35 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 35 | suppressed |
| Ibuprofen | Ibuprofen | 35 | 16 |
| Movantik | Naloxegol Oxalate | 35 | suppressed |
| Neupro | Rotigotine | 35 | suppressed |
| Restasis | Cyclosporine | 35 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 35 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | 12 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 33 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 16 |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Methotrexate | Methotrexate Sodium | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 30 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 30 | 14 |
| Humalog | Insulin Lispro | 30 | suppressed |
| Nyamyc | Nystatin | 30 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Levofloxacin | Levofloxacin | 29 | 22 |
| Pregabalin | Pregabalin | 29 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Clozapine | Clozapine | 28 | suppressed |
| Jardiance | Empagliflozin | 28 | suppressed |
| Linzess | Linaclotide | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Primidone | Primidone | 27 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | suppressed |
| Methylprednisolone | Methylprednisolone | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Multaq | Dronedarone Hcl | 25 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 25 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 24 | 15 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 24 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 24 | suppressed |
| Creon | Lipase/Protease/Amylase | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 23 | 21 |
| Elmiron | Pentosan Polysulfate Sodium | 23 | suppressed |
| Temazepam | Temazepam | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 22 | 22 |
| Metolazone | Metolazone | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 21 |
| Carbamazepine | Carbamazepine | 20 | suppressed |
| Daptomycin | Daptomycin | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Hydroxyurea | Hydroxyurea | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 12 |
| Mesalamine | Mesalamine | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Fosamax Plus D | Alendronate Sodium/Vitamin D3 | 14 | suppressed |
| Glimepiride | Glimepiride | 14 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 14 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Lacosamide | Lacosamide | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 13 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Austedo | Deutetrabenazine | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 11 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Soaanz | Torsemide | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $95.56 · 5 records | Exact Sciences Corporation | Cologuard Collection Kit, FANAPT, REXULTI, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error